Pyridin-3-ylmethyl N-[[4-[[2-[4-(2-hydroxyethyl)piperazin-1-yl]benzoyl]amino]phenyl]methyl]carbamate
C27H31N5O4 — CID 156781178
Data last refreshed: (MolForge compound catalog, from PubChem)
About Pyridin-3-ylmethyl N-[[4-[[2-[4-(2-hydroxyethyl)piperazin-1-yl]benzoyl]amino]phenyl]methyl]carbamate
Pyridin-3-ylmethyl N-[[4-[[2-[4-(2-hydroxyethyl)piperazin-1-yl]benzoyl]amino]phenyl]methyl]carbamate (PubChem CID 156781178) has the molecular formula C27H31N5O4 and a molecular weight of 489.58 g/mol. Its IUPAC name is pyridin-3-ylmethyl N-[[4-[[2-[4-(2-hydroxyethyl)piperazin-1-yl]benzoyl]amino]phenyl]methyl]carbamate.
Molecular Properties
| Compound Name | Pyridin-3-ylmethyl N-[[4-[[2-[4-(2-hydroxyethyl)piperazin-1-yl]benzoyl]amino]phenyl]methyl]carbamate |
|---|---|
| PubChem CID | 156781178 |
| Molecular Formula | C27H31N5O4 |
| Molecular Weight | 489.58 g/mol |
| Exact Mass | 489.24 |
| IUPAC Name | pyridin-3-ylmethyl N-[[4-[[2-[4-(2-hydroxyethyl)piperazin-1-yl]benzoyl]amino]phenyl]methyl]carbamate |
| SMILES | O=C(NCc1ccc(NC(=O)c2ccccc2N2CCN(CCO)CC2)cc1)OCc1cccnc1 |
| InChI | InChI=1S/C27H31N5O4/c33-17-16-31-12-14-32(15-13-31)25-6-2-1-5-24(25)26(34)30-23-9-7-21(8-10-23)19-29-27(35)36-20-22-4-3-11-28-18-22/h1-11,18,33H,12-17,19-20H2,(H,29,35)(H,30,34) |
| InChIKey | WYOGQUUJNMLBBR-UHFFFAOYSA-N |
| XLogP | 2.87 |
| TPSA | 107.03 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 9 |
| Heavy Atoms | 36 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 489.58 |
| LogP ≤ 5 | 2.87 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 156781178 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.